Suejung Jo
Overview
Explore the profile of Suejung Jo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahn B, Kang K, Kim Y, Cho Y, Jo S, Yoo J, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772033
Background: Varicella can lead to severe complications in immunocompromised children, including those undergoing hematopoietic stem cell transplantation (HSCT) or chemotherapy. Preventing primary varicella zoster virus (VZV) infection is crucial in...
2.
Lee J, Lee G, Kim T, Ahn A, Jung J, Kim Y, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682306
: Myeloid neoplasms encompass a diverse group of disorders. In this study, we aimed to analyze the clinical and genomic data of patients with myeloproliferative neoplasm (MPN), myelodysplastic neoplasm (MDS),...
3.
Lee J, Jo S, Yoo J, Kim S, Chung N, Cho B
Blood Res
. 2024 Oct;
59(1):32.
PMID: 39414685
Essential thrombocytosis (ET) is a rare myeloproliferative disease in children, and there are few standard management guidelines. We herein report a case series of 10 pediatric patients with ET diagnosed...
4.
Yoo J, Jo S, Ahn M, Kim S, Lee J, Kim M, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568679
We conducted a retrospective study on 51 pediatric patients with newly diagnosed chronic myeloid leukemia chronic phase or accelerated phase. The patients were classified into the IMA group (N =...
5.
Jo S, Yoo J, Kim S, Lee J, Im S, Cho B, et al.
Front Oncol
. 2023 Apr;
13:1122714.
PMID: 37035148
Most children with chronic myeloid leukemia (CML) present with the chronic phase (CML-CP) at diagnosis, exhibiting an excellent treatment response to contemporary tyrosine kinase inhibitors (TKIs). However, despite TKI therapy,...
6.
Jang W, Jo S, Yoo J, Kim S, Lee J, Jang P, et al.
Blood Res
. 2022 Dec;
57(4):256-263.
PMID: 36535640
Background: Allogeneic HSCT may improve survival in pediatric ALL patients who relapse. In this study, we analyzed the outcome and prognostic factors of 62 ALL patients (35 male, 56.5%) who...
7.
Yoo J, Ahn A, Lee J, Jo S, Kim S, Lee J, et al.
J Clin Med
. 2022 Nov;
11(21).
PMID: 36362526
The wide application of next-generation sequencing (NGS) technologies has led to the discovery of multiple genetic alterations in pediatric acute lymphoblastic leukemia (ALL). In this work, we aimed to investigate...
8.
Jo S, Kang H, Kim S, Lee J, Chung N, Cho B, et al.
Pathogens
. 2021 Sep;
10(9).
PMID: 34578155
Septicemia or bacteremia is one of the leading causes of death worldwide. Long-term tunneled central venous catheters (CVCs) are usually placed in children undergoing chemotherapy or hematopoietic stem cell transplantation...